arrow
P

Patrick Yong

Frimley Health NHS Foundation Trust
H指数:37
被引数:6,297

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Management of hereditary angioedema in the UK: a comparison with international guidelines

英国遗传性血管性水肿的管理:与国际指南的比较

2026-09-080
PRE
Impact of Oral Sebetralstat on Anxiety Associated With Hereditary Angioedema Attacks

奥马珠单抗口服制剂对遗传性血管性水肿发作相关焦虑的影响

2026-03-050
OAAI
National Audit of Long-Term Real-World Outcomes of Berotralstat Use in UK Patients With Hereditary Angioedema

英国遗传性血管性水肿患者使用Berotralstat的长期真实世界结局全国性审计

2025-10-140
PRE
Long-term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label Extension

Sebetralstat的长期安全性与有效性:KONFIDENT-S开放标签扩展研究的期中分析

2025-08-290
OAAI
Clinical presentation and management of 239 children and adolescents with hereditary angioedema

239例遗传性血管性水肿儿童和青少年的临床表现与管理

2025-07-290
PRE
Novel antivirals for severe enterovirus infection in immunocompromised hosts; A case series

免疫功能低下的宿主中严重肠病毒感染的新型抗病毒药物; 病例系列

2024-05-011
OA
Chronic or recurrent Campylobacter enteritis in primary immunodeficiency: A UK national case-series and review of the literature

原发性免疫缺陷的慢性或复发性弯曲杆菌肠炎: 英国国家病例系列和文献综述

2023-09-013
OAAI
A National Survey of Hereditary Angioedema and Acquired C1 Inhibitor Deficiency in the United Kingdom
2023-08-019
OAAI
Effects of Atrioventricular Optimization on Left Ventricular Reverse Remodeling With Cardiac Resynchronization Therapy: Results of the SMART-CRT Trial
2023-06-015
OA
Berotralstat for the prophylaxis of hereditary angioedema-Real-world evidence data from the United Kingdom

Berotralstat用于预防遗传性血管性水肿-来自英国的真实世界证据数据

2023-01-246
OA
Lanadelumab for the prevention of hereditary angioedema attacks: A real-world UK audit
2022-12-213
OA